loading page

Prevalence and distribution of musculoskeletal symptoms in cystic fibrosis and impacts on daily life
  • +4
  • Elizabeth Clarke,
  • Julia Taylor,
  • Pippa Watson,
  • Jane Freeston,
  • Andrew Jones,
  • Daniel Peckham,
  • Alex Horsley
Elizabeth Clarke
The University of Manchester Division of Infection Immunity and Respiratory Medicine

Corresponding Author:elizabeth.clarke@ggc.scot.nhs.uk

Author Profile
Julia Taylor
Manchester University NHS Foundation Trust
Author Profile
Pippa Watson
The University of Manchester Division of Infection Immunity and Respiratory Medicine
Author Profile
Jane Freeston
Leeds Teaching Hospitals NHS Trust
Author Profile
Andrew Jones
The University of Manchester Division of Infection Immunity and Respiratory Medicine
Author Profile
Daniel Peckham
Leeds Teaching Hospitals NHS Trust
Author Profile
Alex Horsley
The University of Manchester Division of Infection Immunity and Respiratory Medicine
Author Profile

Abstract

Background: Musculoskeletal problems are reported in the literature as a common problem for people with cystic fibrosis, with a range of aetiologies including an inflammatory arthritis. However, accurate data on the presentations and prevalence are lacking. The aim of this cohort study was to describe the scale and impact of musculoskeletal symptoms in CF. Methods: A collaboratively designed questionnaire was administered to adults attending two large UK CF centres. Data collected evaluated scale and impact of musculoskeletal symptoms. Results: Results were obtained from 489 patients (response rate 59%). Of these, 49% reported that musculoskeletal symptoms impacted their activities of daily living in the previous year. Back pain was common, occurring in 44% of participants in the preceding week. The knee was the most commonly affected painful peripheral joint, with 26% of participants reporting knee pain within the last week rising to 50% within the last year. Early morning stiffness and joint swelling were markedly less common, suggesting that the majority of musculoskeletal pain in CF is not due to an inflammatory arthritis but is due to other factors. Conclusion: Musculoskeletal problems are common in CF and frequently affect activities of daily living. Symptoms of inflammatory arthritis occurred in only a small minority of individuals. A focused approach to characterising and clarifying the aetiology of musculoskeletal symptoms is needed to inform the management of these disabling symptoms.
10 Jul 2024Submitted to Pediatric Pulmonology
11 Jul 2024Submission Checks Completed
11 Jul 2024Assigned to Editor
11 Jul 2024Review(s) Completed, Editorial Evaluation Pending
14 Jul 2024Reviewer(s) Assigned
25 Sep 2024Editorial Decision: Revise Major
30 Oct 20241st Revision Received
10 Nov 2024Submission Checks Completed
10 Nov 2024Assigned to Editor
10 Nov 2024Review(s) Completed, Editorial Evaluation Pending
10 Nov 2024Reviewer(s) Assigned
12 Nov 2024Editorial Decision: Accept